Performance of three commercial viral load assays, versant human immunodeficiency virus type 1 (HIV-1) RNA bDNA v3.0, Cobas AmpliPrep/Cobas TaqMan HIV-1, and NucliSens HIV-1 EasyQ v1.2, testing HIV-1 non-B subtypes and recombinant variants

Journal of Clinical Microbiology

Volumn 46, Issue 9, 2008, Pages 2918-2923

  Holguín, Africa ^a,b   López, Marisa ^a   Molinero, Mar ^a   Soriano, Vincent ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS RNA;

ARTICLE; ASSAY; COMPARATIVE STUDY; CONTROLLED STUDY; DNA RNA HYBRIDIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; NUCLISENS TEST; PATIENT MONITORING; PHYLOGENY; PHYSICIAN; PLASMA; PRIORITY JOURNAL; SAMPLE; STRUCTURAL GENE; TAQMAN TEST; VERSANT TEST; VIREMIA; VIRUS LOAD; VIRUS STRAIN;

HIV INFECTIONS; HIV-1; HUMANS; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; VIRAL LOAD; VIREMIA;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 53649083887     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02414-07     Document Type: Article

References (31)

1. Berger, A., L. Scherzed, M. Sturmer, W. Preiser, H. W. Doerr, and H. F. Rabenau. 2002. Evaluation of the Cobas AmpliPrep/Cobas Amplicor HIV-1 monitor ultrasensitive test: comparison with the Cobas Amplicor HIV-1 monitor test (manual specimen preparation). J. Clin. Virol. 2002(Suppl. 3):S103-S107.
2. Berger, A., L. Scherzed, M. Stürmer, W. Preiser, H. W. Doerr, and H. F. Rabenau. 2005. Comparative evaluation of the Cobas Amplicor HIV-1 monitor ultrasensitive test, the new Cobas AmpliPrep/Cobas Amplicor HIV-1 monitor ultrasensitive test and the Versant HIV RNA 3.0 assays for quantitation of HIV-1 RNA in plasma samples. J. Clin. Virol. 33:43-51.
3. Böni, J., H. Pyra, M. Gebhardt, L. Perrin, P. Bürgisser, L. Matter, W. Fierz, P. Erb, J. C. Piffaretti, E. Minder, P. Grob, J. J. Burckhardt, M. Zwahlen, and J. Schüpbach. 1999. High frequency of non-B subtypes in new diagnosed HIV-1 infections in Switzerland. J. Acquir. Immune Defic. Syndr. 22:174-179.
4. Booth, C. L., A. M. García-Diaz, M. S. Youle, M. A. Johnson, A. Phillips, and A. M. Geretti. 2007. Prevalence and predictors of antiretroviral drug resistance in newly diagnosed HIV-1 infection. J. Antimicrob. Chemother. 59:517-524.
5. Braun, P., R. Ehret, F. Wiesmann, F. Zabbai, M. Knickmann, R. Kühn, S. Thamm, G. Warnat, and H. Knechten. 2007. Comparison of four commercial quantitative HIV-1 assays for viral load monitoring in clinical daily routine. Clin. Chem. Lab. Med. 45:93-99.
6. Collins, M. L., B. Irvine, D. Tyner, E. Fine, C. Zayati, C. Chang, T. Horn, D. Ahle, J. Detmer, L. P. Shen, J. Kolberg, S. Bushnell, M. S. Urdea, and D. D. Ho. 1997. A branched DNA signal amplification assay for quantification of nucleic acid targets below 100 molecules/ml. Nucleic Acids Res. 25:2979-2984.
7. Damond, F., B. Roquebert, A. Bénard, G. Collin, M. Miceli, P. Yéni, F. Brun-Vézinet, and D. Descamps. 2007. Human immunodeficiency virus type 1 (HIV-1) plasma load discrepancies between the Roche COBAS Amplicor HIV-1 monitor version 1.5 and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 assays. J. Clin. Microbiol. 45:3436-3438.
8. de Mendoza, C., M. Koppelman, B. Montès, V. Ferre, V. Soriano, H. Cuypers, M. Segondy, and T. Oosterlaken. 2005. Multicenter evaluation of the NucliSens EasyQ HIV-1 version 1.1 assay for the quantitative detection of HIV-1 RNA in plasma. J. Virol. Methods 127:54-59.
9. Descamps, D., M. L. Chaix, P. André, V. Brodard, J. Cottalorda, C. Deveau, M. Harzic, D. Ingrand, J. Izopet, E. Kohli, S. Masquelier, S. Mouajjah, P. Palmer, I. Pellegrin, J. C. Plantier, C. Poggi, S. Rogez, A. Ruffault, V. Schneider, A. Signori-Schmück, C. Tamalet, M. Wirden, C. Rouzioux, F. Brun-Vezinet, L. Meyer, and D. Costagliola. 2005. French national sentinel survey of antiretroviral drug resistance in patients with HIV-1 primary infection and in antiretroviral-naive chronically infected patients in 2001-2002. J. Acquir. Immune Defic. Syndr. 38:545-552.
10. Drexler, J. F., L. K. de Souza Luna, C. Pedroso, D. B. Pedral-Sampaio, A. T. Queiroz, C. Brites, E. M. Netto, and C. Drosten. 2007. Rates of and reasons for failure of commercial human immunodeficiency virus type 1 viral load assays in Brazil. J. Clin. Microbiol. 45:2061-2203.
11. Geelen, S., J. Lange, J. Borleffs, T. Wolfs, A. Weersink, and R. Schuurman. 2003. Failure to detect a non-B HIV-1 subtype by the HIV-1 Amplicor monitor test, version 1.5: a case of unexpected vertical transmission. AIDS 17:781-782.
12. Gill, M. J., B. Beckthold, D. Church, and J. Kim. 2007. The impact of genetic diversity on viral load quantification, abstr. TUPEB059. Abstr. 4th IAS Conf. HIV Pathog. Treatment Prevention.
13. Ginocchio, C. C., M. Kemper, K. A. Stellrecht, and D. J. Witt. 2003. Multicenter evaluation of the performance characteristics of the NucliSENS HIV-1 QT assay used for quantitation of human immunodeficiency virus type 1 RNA. J. Clin. Microbiol. 41:164-173.
14. Gueudin, M., J. C. Plantier, V. Lemée, M. P. Schmitt, L. Chartier, T. Bourlet, A. Ruffault, F. Damond, M. Vray, and F. Simon. 2007. Evaluation of the Roche Cobas TaqMan and Abbott RealTime extraction- quantification systems for HIV-1 subtypes. J. Acquir. Immune Defic. Syndr. 44:500-505.
15. Holguín, A., B. Aracil, A. Álvarez, C. Barros, and V. Soriano. 2001. Prevalence of HIV-1 non-B subtypes in foreigners living in Madrid, Spain, and comparison of the performance of the Amplicor HIV-1 Monitor version 1.0 and the new automated version 1.5. J. Clin. Microbiol. 39:1850-1854.
16. Holguín, A., A. Alvarez, M. J. Pena, F. Artiles, L. Molina, and V. Soriano. 2003. HIV-positive immigrants in the Canary Islands, Spain: implications for public health in Europe. HIV Clin. Trials 4:184-192.
17. Holguín, A., A. Álvarez, and V. Soriano. 2005. Heterogeneous nature of HIV-1 recombinants spreading in Spain. J. Med. Virol. 75:374-380.
18. Holguín, A., M. J. Pena, F. Troncoso, and V. Soriano. 2007. Introduction of non-B subtypes among Spaniards newly diagnosed with HIV-1 in the Canary Islands. AIDS Res. Hum. Retrovirol. 23:498-502.
19. Holguín, A., M. López, and V. Soriano. 2007. Reliability of rapid subtyping tools compared to phylogenetic analysis for characterization of HIV-1 non-B subtypes and recombinant forms, abstr. P17.2/01. Abstr. 11th Eur. AIDS Conf.
20. Kamat, A., V. Ravi, A. Desai, P. Satishchandra, K. S. Satish, I. Borodowsky, D. K. Subbakrishna, and M. Kumar. 2007. Quantitation of HIV-1 RNA levels in plasma and CSF of asymptomatic HIV-1-infected patients from South India using a TaqMan real-time PCR assay. J. Clin. Virol. 39:9-15.
21. Lam, H. Y., J. H. K. Chen, K. H. Wong, K. Chan, P. Li, M. P. Lee, D. N. Tsang, K. Y. Yuen, and W. C. Yam. 2007. Evaluation of NucliSens EasyQ™ HIV-1 assay for quantification of HIV-1 subtypes prevalent in South-east Asia. J. Clin. Virol. 38:39-43.
22. Lospitao, E., A. Alvarez, V. Soriano, and A. Holguín. 2005. HIV-1 subtypes in Spain: a retrospective analysis from 1995 to 2003. HIV Med. 6:313-320.
23. + lymphocytes as prognostic markers of HIV-1 infection. Ann. Intern. Med. 126:946-954.
24. Murphy, D. G., L. Côté, M. Fauvel, P. René, and J. Vincelette. 2000. Multicenter comparison of Roche COBAS AMPLICOR MONITOR version 1.5, Organon Teknika NucliSens QT with Extractor, and Bayer Quantiplex version 3.0 for quantification of human immunodeficiency virus type 1 RNA in plasma. J. Clin. Microbiol. 38:4034-4041.
25. Parekh, B., S. Phillips, T. Granade, J. Baggs, D. J. Hu, and R. Respess. 1999. Impact of HIV type 1 subtype variation on viral RNA quantitation. AIDS Res. Hum. Retrovirol. 15:133-142.
26. Rouet, F., M. L. Chaix, E. Nerrienet, N. Ngo-Giang-Huong, J. C. Plantier, M. Burgard, M. Peeters, F. Damond, D. K. Ekouevi, P. Msellati, L. Ferradini, S. Rukobo, V. Marechal, N. Schvachsa, L. Wakrim, C. Rafalimanana, B. Rakotoambinina, J. P. Viard, J. M. Seigneurin, C. Rouzioux, et al. 2007. Impact of HIV-1 genetic diversity on plasma HIV-1 RNA quantification: usefulness of the Agence Nationale de Recherches sur le SIDA second-generation long terminal repeat-based real-time reverse transcriptase polymerase chain reaction test. J. Acquir. Immune Defic. Syndr. 45:380-388.
27. Schumacher, W., E. Frick, M. Kauselmann, V. Maier-Hoyle, R. van der Vliet, and R. Babiel. 2007. Fully automated quantification of human immunodeficiency virus type 1 RNA in human plasma by the COBAS® Ampli-Prep/COBAS® TaqMan® system. J. Clin. Virol. 38:304-312.
28. Schutten, M., D. Peters, N. K. Back, M. Beld, K. Beuselinck, V. Foulongne, A. M. Geretti, L. Pandiani, C. Tiemann, and H. G. Niesters. 2007. Multicenter evaluation of the new Abbott RealTime assays for quantitative detection of human immunodeficiency virus type 1 and hepatitis C virus RNA. J. Clin. Microbiol. 45:1712-1717.
29. Stevens, W., T. Wiggill, P. Horsfield, L. Coetzee, and L. E. Scott. 2005. Evaluation of the NucliSENS EasyQ assay in HIV-1-infected individuals in South Africa. J. Virol. Methods 124:105-110.
30. Sun, R., J. Ku, H. Jayakar, J. C. Kuo, D. Brambilla, S. Herman, M. Rosenstraus, and J. Spadoro. 1998. Ultrasensitive reverse transcription-PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma. J. Clin. Microbiol. 36:2964-2969.
31. Tatt, I. D., K. L. Barlow, J. P. Clewley, O. N. Gill, and J. V. Parry. 2004. Surveillance of HIV-1 subtypes among heterosexuals in England and Wales, 1997-2000. J. Acquir. Immune Defic. Syndr. 36:1092-1099.